Should erectile dysfunction be treated as secondary prevention for coronary disease?
First published: 11 October 2006
No abstract is available for this article.
References
- 1
Montorsi P,
Ravagnani PM,
Galli S
et al.
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial.
Eur Heart J
2006
(doi:10.1093/eurheartj/ehl142).
- 2
Jackson G.
Erectile dysfunction: a marker of silent coronary artery disease.
Eur Heart J
2006 (doi:10.1093/eurheartj/ehl110).
- 3
Montorsi F,
Briganti A,
Salonia A
et al.
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.
Eur Urol
2003; 44: 360–5.
- 4
Jackson G.
The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism.
Eur Urol
2006; 50: 426–7.
- 5
Solomon H,
Man JW,
Jackson G.
Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator.
Heart
2003; 89: 251–3.
- 6
Solomon H,
Wierzbicki AS,
Lumb PJ
et al.
Cardiovascular risk factors determine erectile and arterial function response to sildenafil.
Am J Hypertens
2006; 19: 915–9.
- 7
JSB 2.
Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice.
Heart
2005; 91: V1–52.
- 8
Thompson IM,
Tangen CM,
Goodman PJ
et al.
Erectile dysfunction and subsequent cardiovascular disease.
JAMA
2005; 294: 2996–3002.
- 9
Jackson G,
Rosen RC,
Kloner RA
et al.
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.
J Sex Med
2006; 3: 28–36.
- 10
Gazzaruso C,
Giordanetti S,
De Amici E
et al.
Relationship between erectile dysfunction and silent myocardial ischaemia in apparently uncomplicated type 2 diabetic patients.
Circulation
2004; 110: 22–6.
